Growth Hormone and the Acquisition of Bone Mass

Hormone Research in Paediatrics

Volumn 48, Issue 5, 1997, Pages 72-77

  Johannsson, G ^a   Bengtsson, B A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone mass; Bone metabolism; Bone mineral content; Bone mineral density; Gonadal steroids; Growth hormone treatment

Indexed keywords

ANDROGEN RECEPTOR; BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; ESTROGEN RECEPTOR; GROWTH HORMONE; HUMAN GROWTH HORMONE; SEX HORMONE; SOMATOMEDIN C;

BONE DENSITY; BONE MASS; BONE MATURATION; BONE METABOLISM; BONE MINERAL; BONE REMODELING; CELL DIFFERENTIATION; CONFERENCE PAPER; GONAD FUNCTION; GROWTH HORMONE DEFICIENCY; HIP FRACTURE; HORMONAL THERAPY; HUMAN; LUMBAR SPINE; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RISK; SEX DIFFERENCE; SHORT STATURE; STEM CELL; VERTEBRA FRACTURE;

BONE AND BONES; BONE DEVELOPMENT; FEMALE; GROWTH HORMONE; HUMANS;

EID: 0030808790     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000191332     Document Type: Article

References (65)

1. Manolagas SC, Jilka RL: Boric marrow, cytokines, and bone remodelling. N Engl J Med 1995;332:305-311.
2. Ohlsson C, Isgaard J, Tsmell J, Nilsson A, Isaksson OGP. Lindahl A: Endocrine regulation of longitudinal bone growth. Acta Pacdiatr 1993:39l(suppl):33-40.
3. Raisz LG: Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 1988;318:818-828.
4. Dc Boer H, Blok GJ, Van Lingen A, Teulc GJJ, Lips P, Van Der Veen EA: Consequences of childhood-onset growth hormone deficiency of adult bone mass. J Bone Miner Res 1994;9: 1319-1326.
5. Kaufman JM, Taelman P, Vernrculen A, Van-deweghe M: Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Mctab 1992:74:118-123.
6. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM: Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 1993; 76:1344-1348.
7. Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Zachman M, Christiansen C: Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy. J Clin Endocrinol Mctab 1990:71:122-126.
8. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM: Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Mctabol 1994:78:669-674.
9. Johannsson AG, Burman P, Westermark K, Ljunghall S: The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor. J Intern Med 1992;232:447-452.
10. Rosen T, Hansson T, Granhcd H. Sziics J, Bengtsson B-A: Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol 1993;129:201-208.
11. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Sacca L, Bellastclla A: Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficicnt adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1993:77:1671-1676.
12. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen JOL, Hassangcr C. Christiansen C: The effects of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-dcficient adults. Clin Endocrinol 1991;35:471-476.
13. Wüster CHR, Slenczka E, Ziegler R: Arteriosklerose bei konventionell substituierter hyo-physenvordertappeninsufTizienz: bedarf einer zusätzlichen Wachstumshormonsubstitution? Klin Wochenschr 1991;69:769-773.
14. Hyer SL, Rodin DA, Tobias JH, Leiper A, Nus-sey SS: Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child 1992;67:1472-1474.
15. Degcrblad M, Elgindy N, Hall K, Sjöberg H-E, Thoren M: Potent effect of recombinant human growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol 1992; 126:387-393.
16. Baum MB, Biller BMK, Finkelstein JS, Canni-straro KB. Oppenheim DS. Schocnfcld AD, Michel TH. Wittink H. Klibanski A: Effects of physiological growth-hormone therapy on bone-density and body-composition in patients with adult-onset growth-hormone-deficiency -randomized, placebo-controlled trial. Ann Intern Med 1996;125:883-890.
17. Saggcse G, Baroncelli Gl, Bertelloni S, Barsanti S: The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996:81:3077-3083.
18. Rosin T, Bengtsson B-Ä: Premature mortality due to cardiovascular diseases in hypopituitarism. Lancet 1990;336:285-288.
19. Johansen JS, Pedersen SA, Jorgensen JOL, Riis J. Christiansen C. Christiansen SJ. Skakkebaik NE: Effects of growth hormone (GH) on plasma bone GLA protein in GH-deficient adults. J Clin Endocrinol Metab 1990;70:916-919.
20. Binncrts A, Swart GR, Wilsson JHP, Hooger-brugge N, Pois HAP, Birkenhager JC, Lamberts SWJ: The effects of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol 1992;37:79-87.
21. Vandeweghe M, Taclman P, Kaufman JM: Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 1993:39:409-415.
22. Bengtsson B-Ä, Eden S, Lönn L, Kvist H, Stok-land A, Lindstedt G, Bosaeus I, Tölli J, Sjö-ström L. isaksson OGP: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309-317.
23. Beshvah SA, Thomas E, Kyd P, Sharp P, Fair-ncy A. Johnston DG: The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol 1994:40:383-391.
24. Thoren M, Soop M, Degerblad M, Sääf M: Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency. Acta Endocrinol 1993;128(suppl 2):41-43.
25. Juul A, Pedersen S, Sorensen S, Winkler K, Jorgensen JOL, Christiansen JS, Skakkcbtck NE: Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood-onset. Eur J Endocrinol 1994:131:41-49.
26. Whitehead H, Boreman C, Mcllrath EM. Sheridan B, Kennedy L, Atkinson AB, Hadden DR: Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol 1992;36:45-52.
27. Johannsson G, Rosen T, Bosaeus I, Sjöström L, Bengtsson B-Ä: Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 1996;81:2865-2873.
28. Rosen T, Johannsson G, Hallgren P, Caidahl C, Bosaeus I, Bengtsson B-Ä: Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinol Metab 1994; 1:55-66.
29. Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM: Effects of growth hormone replacement on bone mass in adult onset growth hormone deficiency. Clin Endocrinol 1995;42:627-633.
30. Hansen TB, Brixcn K, Vahl N, Jorgensen JO, Christiansen JS, Mosckilde L, Hagen C: Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab 1996:81:3352-3359.
31. Beshyah SA, Kyd P, Thomas E, Faimey A, Johnston DG: The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol 1995:42:249-254.
32. Degerblad M, Bengtsson B-Ä, Bramnert M, Johnell O, Manhem P, Rosin T, Thoren M: Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapv. Eur J Endocrinol 1995:133: 180-188.
33. Sceman E, Wahner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL: Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 1982:69: 1302-1309.
34. Svendsen OL, Hassager C, Skodt V. Christiansen C: Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip. and forearm: a human cadaver study. J Bone Miner Res 1995:10:868-873.
35. Sandstedt J, Tomell J, Norjavaara E, Isaksson OGP, Ohlsson C: Elevated levelsofgrowth hormone increase bone mineral content in normal young mice, but not in ovariectomized mice. Endocrinology 1996; 137:3368-3374.
36. Katzman DK, Bachrach LK, Carter DR, Marcus R: Clinical and anthropodometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 1991: 73:1332-1339.
37. Andrcassen TT, Jorgensen PH, Flyvbjerg A, Orskov H, Oxlund H: Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 1995:10: 1057-1067.
38. Wood AJJ: The prevention and treatment of osteoporosis. N Engl J Med 1992;327:620-627.
39. Heaney RP: The bone-remodelling transient: implications for the interpretation of clinical studies of bone mass change. J Bone Miner Res 1994:9:1515-1523.
40. Holmes SJ, Whitehouse RW, Economou G, O’Halloran DJ, Adams JE, Shalet SM: Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. Clin Endocrinol 1995;42:3-7.
41. Isaksson OGP, Lindahl A, Nilsson A. Isgaard J: Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987:8:426-437.
42. Green H, Morikawa M, Nixon T: A dual effector theory of growth hormone action. Differentiation 1985;29:195-198.
43. Kassent M, Blum W, Ristelli J, Moskilde L, Eriksen EF: Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 1993:52:222-226.
44. Nilsson A, Swolin D, Enerback S, Ohlsson C: Expression of functional growth hormone receptors in cultured human osteoblast-like cells. J Clin Endocrinol Metab 1995:80:3483-3488.
45. Nishiyama K, Sugimoto T, Kaji M, Kobayashi T, Chihara K: Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. Endocrinology 1996;137:35-41.
46. Swolin D, Ohlsson C: Growth hormone increases interleukin-6 produced by human os-teoblast-like cells. J Clin Endocrinol Metab 1996:81:4329-4333.
47. Liebemian SA, Holloway L, Marcus R, Hoffman AR: Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium. and calcitriol metabolism and bone remodelling in postmenopausal women. J Bone Miner Res 1994:9:1723-1728.
48. Spencer EM, Tobiassen O: The mechanism of the aclion of growth hormone on vitamin D metabolism in the rat. Endocrinology 1981: 108:1064-1070.
49. Spanos E, Barret D, MacIntyre I, Pike J, Safil-ial EF, Haussler MR: Effect of growth hormone on vitamin D metabolism. Nature 1978;273: 246-247.
50. Chen Z, Lohman TG, Stini WA, Rilenbaugh C, Aickin M: Fat or lean tissue mass: which one is the major determinant of bone mineral mass in healthy postmenopausal women. J Bone Miner Res 1997;12:144-151.
51. Bumian P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hägg E, Karlsson FA: Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Mctab 1995;80: 3585-3590.
52. Cuneo RC, Salomon F, Wiles CM, Ilesp R, Sönksen PH: Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appi Physiol 1991;70: 695-700.
53. Nass R, Huber RM, Klauss V, Müller OA, Schopohl J, Strasburger CJ: Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Mctab 1995:80:552-557.
54. Cuneo RC, Salomon F, Wilmhurst P, Byrne C, Wiles CM, Hesp R, Sönkscn PH: Cardiovascular effects of growth hormone treatment in growth-hormone-dcficient adults: stimulation of the renin-aldosterone system. Clin Sci 1991; 81:587-592.
55. Aloia JF, Vaswani AN, Yeh JK, Cohn SH: Premenopausal bone mass is related to physical activity. Arch Intern Med 1988:148:121-123.
56. Block JE, Genant HR, Black D: Greater vertebral bone mineral mass in exercising young men. West J Med 1986:145:39-42.
57. Dalskv GP, Slocke KS, Ehsani AA, Slatopolsky E, Lee WC, Birge SJ Jr: Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med 1988:108:824-828.
58. Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ: Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodelling. J Clin Endocrinol Metab 1989:69:523-527.
59. Mann DR, Rudman CG, Akinbami MA, Gould KG: Preservation of bone mass in hypo-gonadal female monkeys with recombinant human growth hormone administration. J Clin Endocrinol Metab 1992:74:1263-1269.
60. Eschen C, Andrcassen TT: Growth hormone normalizes vertebral strength in ovariccto-mized rats. Calcif Tissue Int 1995:57:392-396.
61. Melton III LJ, Atkinson EJ, O’Fallon WM, Wahner HW, Riggs BL: Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993:8: 1227-1233.
62. Cummings SR, Black DM. Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM: Bone density at various sites for prediction of hip fracture. Lancet 1993:341:72-75.
63. Rcckcr RR: Current therapy for osteoporosis. J Clin Endocrinol Mctab 1993;76:14-16.
64. Rosen T, Wilhclmsen L, Landin-WUhelmscn K, Lappas G, Lindstcdt G, Bengtsson B-A: Increased fracture rate in growth hormone deficient adults. Eur J Endocrinol 1997; in press.
65. Bravenboer N, Holzmann P, De Boer H, Blok GJ, Lips P: Histomorphometric analysis of bone mass and bone metabolism in growth hormone deficient adult men. Bone 1996:18:551-557.